YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
(RTTNews) - XTL Biopharmaceuticals Ltd. (XTLB) announced the completion of the acquisition of Psyga Bio Ltd. With the transaction's closure, psychedelic operations will become XTL's exclusive core business, the company said. Psyga Bio deve…
expands its IP portfolio to clinical-stage biopharmaceutical assets XTL Biopharmaceuticals (XTL) Completes the Acquisition of Psyga Bio and Establishes Psychedelic Biotechnology Platform At a historic juncture and with unprecedented regula…
XTL Biopharmaceuticals Ltd. RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) from The Listin…
* XTL Biopharmaceuticals (XTLB [https://seekingalpha.com/symbol/XTLB]) will change its ADS ratio [https://seekingalpha.com/pr/20446334-xtl-biopharmaceuticals-announces-ads-ratio-change] from 1:100 to 1:400 effective March 25, 2026. * The m…
RAMAT GAN, ISRAEL, March 20, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it plans to change the ratio of its American Depositary Shares ("ADSs") to its or…
XTL Biopharmaceuticals Ltd. RAMAT GAN, ISRAEL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter from The Listing…
Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying therapies exist FDA Orphan D…
* XTL Biopharmaceuticals (XTLB [https://seekingalpha.com/symbol/XTLB]) received [https://seekingalpha.com/pr/20349010-xtl-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency] a Nasdaq notice dated Decembe…
RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter from The Listing Qualifications Department o…
XTL Biopharmaceuticals Ltd. RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter from The Listing…
XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) announced Monday that shareholders approved all proposals at the company’s Annual and Extraordinary General Meeting, held in Bnei Brak, Israel. The information is based on a statement released thro…
XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB, (TASE:XTLB).TA) announced Monday the postponement of its annual and extraordinary shareholders’ meeting, which had been scheduled for Monday, after legal quorum requirements were not met. The compa…
Brings a Wealth of Managerial Experience and Track Record RAMAT GAN, ISRAEL, April 07, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”) announced today the appointment of Noam Band…
Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets consists of an IP portfolio relating to h…
Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets consists of an IP portfolio relating to h…
Former CEO/Director Dr. Morris C. Laster Believes Immediate Change is Required to Scopus's Board to Ensure Effective, Independent Oversight of Company's Affairs Deeply Concerned about Allegations of Malfeasance, Misappropriation of Company…
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion. Vivos Therapeutics, Inc.…
Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X signed a Memorandum of Understanding with Silkwave Holdings to…
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 175% to $17.33. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option. GeoVax Labs, Inc. (NASDAQ: GOVX) shares climbed 45.8% to $6.27…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 13) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Atea Pharmaceuticals Inc (NASDAQ: AVIR) Bioanal…
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) AbbVie Inc (NYSE: ABBV) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) Aldeyra Therapeutics Inc (…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 29) ABIOMED, Inc. (NASDAQ: ABMD) Apellis Pharmaceuticals Inc (NASDAQ: APLS) Atea Pharmaceuticals…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Aclaris Therapeutics Inc (NASDAQ: ACRS) Allakos Inc (NASDAQ: ALLK) Apellis Pharmaceuticals I…
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 17) Acceleron Pharma Inc (NASDAQ: XLRN) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) AtriCure In…
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 17) Acceleron Pharma Inc (NASDAQ: XLRN) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) AtriCure In…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 16) Aclaris Therapeutics Inc (NASDAQ: ACRS) Bioanalytical Systems, Inc. (NASDAQ: BASI) BioLife S…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 14) Acceleron Pharma Inc (NASDAQ: XLRN) (announced orphan drug designation for sotatercept in pu…
Yoqneam, Israel, July 01, 2020 (GLOBE NEWSWIRE) -- Seedo Corp. (OTC: SEDO) (“Seedo”) announced its shareholders have elected a new Board of Directors. The new Board brings decades of executive corporate, business and financial experience t…
NEW YORK, May 07, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Eagle Materials Inc (N…
NEW YORK, Nov. 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Discovery, Inc. (NASD…
TEL-AVIV, Israel, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) ("Cellect" or the "Company"), a developer of innovative technology which enables the functional selection of stem cells, announced additions to its manageme…